Changes in Genital Inflammatory Biomarkers Associated with HIV pathogenesis in Survivors of Acute Sexual Assault by Bethala, Liana et al.
Changes in Genital Inflammatory Biomarkers Associated with HIV pathogenesis in 
Survivors of Acute Sexual Assault




The mechanisms of how sexual violence affects women’s risk for HIV 
remains unclear. Women are more likely to be affected by HIV/AIDS, as 
over 50% of all HIV infections were in women, particularly in young 
women1. Women are also disproportionately affected by sexual 
violence. In the United States alone, sexual assault is the sixth leading 
cause of injury in women2. Three longitudinal studies from Africa, for 
example, showed that intimate partner violence was associated with a 
50% increase in HIV infection1. 
Increased HIV acquisition has been shown to be associated with 
inflammation in the genital tract3. Previous studies have also shown 
that there was a significant association between sexual assault and 
genital immune biomarkers linked to inflammation in women who 
experience life-long chronic sexual violence2.
This study will evaluate the following biomarkers in survivors of acute 
sexual violence: cytokines interleukin 1 alpha (IL-1ɑ), interleukin 1 beta 
(IL-1β), tumor necrosis factor alpha (TNF-ɑ), and interleukin 6 (IL-6), and 
chemokine macrophage inflammatory protein-3 (MIP-3ɑ). IL-1ɑ is a 
primary cytokine involved in the production of inflammation4. IL-1β is a 
mediator of that inflammatory response and is involved in immune cell 
proliferation, differentiation, and apoptosis4. TNF-ɑ is also involved in 
the systemic inflammation and the acute phase reaction, and it is an 
important regulator of immune cells4. IL-6 is both a pro-inflammatory 
and anti-inflammatory cytokine; it mediates fever and the acute phase 
response, which is a part of the body’s innate immune 
response4. MIP3ɑ attracts lymphocytes and is a known anti-HIV factor5.
The principal aim of this study is to investigate the levels of genital 
inflammatory biomarkers in survivors of acute sexual assault violence. It 
is hypothesized that there will be an increase in biomarkers levels in 
Cases compared to Controls and inflammation will be highest 
immediately after assault.
Recruitment: Cases were collected from the Women and Infants
Hospital of Rhode Island (WIHR) from women who experienced sexual
assault within 5 days before their first visit to the clinic. Controls were
taken from a previous study and were women recruited from the
Washington D.C. metro community who have never experienced sexual
assault.
Enzyme-Linked Immunosorbent Assay (ELISA): Cervicovaginal lavage
(CVL) samples were collected. Each sample was tested in triplicate for
IL-1ɑ, IL-1β, TNF-ɑ, IL-6, and MIP-3ɑ according to manufacturer ’s
protocol (R&D Systems).
Statistical Analysis: Median values of IL-1ɑ, IL-1β, TNF-ɑ, IL-6, and
MIP-3ɑ of the cases and controls were compared using Mann-Whitney
U test. The hour of the first clinic visit after the assault for each
biomarker were compared to each other using Kruskal-Wallis ANOVA
test. Graphs were created using Graphpad PRISM.
• Significant changes in inflammatory biomarkers IL-1 ⍺, IL-1β,
and TNF-⍺ between cases and controls. IL-1 ⍺ and IL-1β were 
increased, while TNF-⍺ was decreased, 
• Significant changes in IL-1⍺ and  IL-6 when comparing the hour 
of arrival to the clinic after the assault. IL-1⍺ and  IL-6 were 
increased in the 0-12 hours compared to the 13-24 hours and 
the 25-72 hours.
• This finding suggests an immediate inflammatory immune 
response following a sexual assault, which has the potential of 
increasing HIV risk in these women.
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Future Directions 
• Measure expression and perform statistical analysis of anti-
inflammatory and wound-healing biomarkers.
• Understand mechanisms of  wound-healing through in vitro cell 
culture-based model for   TNF-⍺, IL-1 ⍺, and IL-1β.
• Compare these results to other sexual assault studies with 
chronic and non-acute survivors .
Table 1: Demographic Information
Fig. 1: Differential expression of biomarkers in Cases vs. Controls 
Fig. 2: Changes in biomarkers based on time after assault 
Table 2: Differences in Biomarkers
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